The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
look on investegate .co. uk
https://www.investegate.co.uk/omega-diagnostics-gp--odx-/rns/visitect--cd4-advanced-disease---supply-agreement/202004280700100470L/
Sort it out LSE, people are missing information!
28 April 2020
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
VISITECT® CD4 Advanced Disease
Supply Agreement with Clinton Health Access Initiative, Inc.
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases, food intolerance and allergy testing, announces that it has signed a supply agreement ("Agreement") with Clinton Health Access Initiative, Inc. ("CHAI")1.
The objective of the Agreement is to accelerate access to Omega's VISITECT® CD4 Advanced Disease rapid test2 in low-income countries, lower-middle income countries and upper-middle income countries (together "Eligible Countries") as classified by the World Bank. The VISITECT® CD4 Advanced Disease Test is the only currently available handheld lateral flow point of care test for identifying patients with advanced HIV who are at risk of potentially life-threatening opportunistic infections.
The Agreement runs until 31 December 2021, during which time CHAI, with support from Unitaid3, will procure up to a maximum of 500,000 VISITECT® CD4 Advanced Disease tests. Within 14 days of signing the Agreement, CHAI will place an initial purchase order for 100,000 tests with delivery dependent upon demand being confirmed by certain Eligible Countries. We expect demand to be confirmed by Eligible Countries later this quarter with shipment to follow thereafter.
The supply of VISITECT® CD4 Advanced Disease tests under the Agreement will help to inform Eligible Countries with national implementation planning to support routine use of the test.
Colin King, CEO of Omega commented: "We are pleased that Omega has been able to enter into this supply agreement with CHAI, who have been very supportive towards accelerating the availability of our VISITECT® CD4 Advanced Disease. This test will help support the healthcare needs of the many people in those countries that are most in need. "
Dont think many people know its here. LSE is playing up
I got in yesterday to HEMO on the dip, not seen one here yet...
Yes it would, I got in to ODX around 28 and was thinking the same I do about this share. everyone was chasing NCYT and AVCT and ODX was just bubbling away.
I think its the same here, bit of a hype this morning but I think its carmed down now and it will slowly climb
This is a much better day, the SP is stable is not bouncing all over the place.
Its better that the SP is is stable + or – 5% each day than having a massive drops or spikes, which bring in the rampers and de ramper brigade!
This shows that that were in a good place now and people happy to wait for news, we know its coming.
Sorry if this has been posted already.
https://www.valuethemarkets.com/2020/04/22/omega-diagnostics-ramps-up-covid-19-antibody-tests-to-1-million-a-month-could-fly-higher-odx/